BioTechnique is redefining the landscape of aseptic fill-finish and lyophilization services. This full-service Contract Research, Development, and Manufacturing Organization (CRDMO) has announced an expansion of its capabilities, which now encompass integrated support from initial development stages right through to commercial supply.

Comprehensive Service Offerings
The recent upgrades to BioTechnique’s platform include a robust third-party logistics (3PL) system, which ensures controlled warehousing across various temperature conditions. This flexibility allows for the safe storage of pharmaceutical products under ambient, refrigerated, frozen, ultra-low, and cryogenic conditions. The integrated services cater to a wide array of formats, including vials, prefilled syringes, cartridges, and bags.
With an end-to-end approach, BioTechnique provides a seamless process that encompasses formulation, compounding, sterile filtration, filling, stoppering, optional lyophilization, capping, quality control testing, visual inspection, labeling, and packaging. All these are managed through the advanced ACE® cloud electronic Quality Management System (eQMS), facilitating real-time documentation and ensuring compliance with stringent regulatory requirements.
Advanced Lyophilization Cycle Development
BioTechnique’s expertise in lyophilization cycle development is a significant addition to its service offerings. The comprehensive cycle development includes formulation support, cycle design and optimization, scale-up, validation, quality assurance, and final product testing. This meticulous approach guarantees that all processes are inspection-ready, safeguarding product integrity throughout its shelf life.
The company has also strengthened its lyophilization capabilities through collaboration with Dr. Serguei Tchessalov, a well-respected expert in freeze-drying technology. This partnership enhances the overall client experience, ensuring that innovative solutions are available from early development to market launch.
Streamlined Quality Assurance
Quality assurance is a cornerstone of BioTechnique’s operations. The integrated ACE® eQMS not only streamlines documentation but also allows for real-time tracking of quality metrics. This system supports audit-ready reporting, which is crucial for meeting regulatory expectations. By minimizing handoffs in the production process, BioTechnique ensures faster timelines and greater efficiency, making it a reliable partner for pharmaceutical companies.
Versatile 3PL Services
BioTechnique’s 3PL services are designed to support the entire fill and lyophilization lifecycle. The platform includes electronic inventory monitoring and temperature tracking, ensuring that all products are stored under optimal conditions. Clients have the option for custom access to monitor their inventory, enhancing transparency and control.
Additionally, the 3PL infrastructure accommodates a variety of storage needs, ranging from ambient and refrigerated to ultra-low and cryogenic conditions. This versatility is essential for handling drug substances, drug products, excipients, samples, and consumables, making BioTechnique a one-stop solution for pharmaceutical developers.
Efficient Freight Solutions
Understanding the complexities associated with shipping temperature-sensitive pharmaceuticals, BioTechnique offers GDP-aligned freight options. These solutions include real-time tracking and documented chain-of-custody processes, ensuring that products remain secure and compliant throughout their journey. This commitment to excellence in logistics further solidifies BioTechnique’s position as a leader in the CRDMO sector.
Commitment to Quality and Innovation
As a division of PSC Biotech Corporation, BioTechnique is dedicated to providing high-quality fill-finish services across a diverse range of pharmaceutical products, including cytotoxic and highly potent compounds, therapeutics, antibody-drug conjugates (ADCs), and vaccines. The company operates a state-of-the-art facility, designed to adapt to the specific requirements of various formulations while maintaining strict quality control standards.
Conclusion
BioTechnique’s expansion in aseptic filling and lyophilization services marks a significant step forward in the pharmaceutical industry. By offering a comprehensive suite of capabilities integrated with advanced quality management, the company is poised to meet the evolving needs of drug developers. With a focus on innovation and efficiency, BioTechnique sets a new standard for fill-finish solutions, ensuring the integrity of critical medical products from development to delivery.
- Key Takeaways:
- BioTechnique enhances its CRDMO services with expanded aseptic filling and lyophilization capabilities.
- The company utilizes an integrated 3PL system for comprehensive temperature-controlled storage solutions.
- Collaborations with industry experts enhance the quality and effectiveness of lyophilization cycle development.
- Advanced eQMS supports real-time quality assurance and streamlined documentation processes.
- Efficient freight options ensure compliance and safety for temperature-sensitive pharmaceuticals.
Read more → www.indystar.com
